GlassScriptPhysician profile
Thomas Zouki
NPI 1346624608
$8,893.74
in general payments reported to CMS, 2019-2025
18 companies · $556 in 2025
The $556 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,646 · 2020: $395 · 2021: $425 · 2022: $885 · 2023: $1,294 · 2024: $2,692 · 2025: $556.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,036 · Travel and Lodging: $506.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,036.30 |
| Travel and Lodging | $506.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,261.83 | 2019-2025 | Superion Indirect Decompression System, General - Pain Management, Intracept |
| Stryker Corporation | $1,381.78 | 2019 | |
| Abbott Laboratories | $1,162.32 | 2019-2024 | Eterna |
| Nevro Corp. | $983.26 | 2020-2024 | Senza |
| Nalu Medical, INC. | $742.09 | 2021-2025 | Nalu Neurostimulation System |
| Vertos Medical, INC. | $472.19 | 2020-2024 | Mild Device Kit |
| Saluda Medical Americas, INC. | $174.31 | 2024-2025 | Evoke |
| Spr Therapeutics, INC | $149.06 | 2023 | Sprint Pns System |
| Teva Pharmaceuticals USA, INC. | $146.48 | 2019 | |
| Medtronic, INC. | $130.66 | 2023 | Intellis Adaptivestim |
| Medtronic USA, INC. | $102.85 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $57.53 | 2021 | |
| Amgen INC. | $31.26 | 2019 | |
| Convatec INC. | $28.98 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $24.86 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $15.20 | 2025 | Senza |
| Lilly USA, LLC | $14.58 | 2020 | |
| Collegium Pharmaceutical, INC. | $14.50 | 2025 | Xtampza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Zouki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.